Amy W Schulman - Net Worth and Insider Trading
Amy W Schulman Net Worth
The estimated net worth of Amy W Schulman is at least $7 Million dollars as of 2024-04-29. Amy W Schulman is the Executive Vice President of Pfizer Inc and owns about 227,003 shares of Pfizer Inc (PFE) stock worth over $6 Million. Amy W Schulman is the Director of Zoetis Inc and owns about 5,000 shares of Zoetis Inc (ZTS) stock worth over $799,800. Amy W Schulman is also the Director of Cyclerion Therapeutics Inc and owns about 31,681 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $97,577. Besides these, Amy W Schulman also holds SQZ Biotechnologies Co (SQZB) . Details can be seen in Amy W Schulman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amy W Schulman has not made any transactions after 2021-12-13 and currently still holds the listed stock(s).
Transaction Summary of Amy W Schulman
Amy W Schulman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy W Schulman owns 13 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Cyclerion Therapeutics Inc (CYCN) , and Hudson Executive Investment Corp (HECCU) among others .
Click here to see the complete history of Amy W Schulman’s form 4 insider trades.
Insider Ownership Summary of Amy W Schulman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2015-06-01 | director |
CYCN | Cyclerion Therapeutics Inc | 2019-04-08 | director |
HECCU | Hudson Executive Investment Corp | 2020-06-08 | director |
IRWD | Ironwood Pharmaceuticals Inc | 2017-01-01 | director |
XFOR | X4 Pharmaceuticals Inc | 2017-11-15 | director |
BUFF | Blue Buffalo Pet Products Inc | 2018-04-24 | director |
BINDQ | DNIB Unwind Inc | 2015-06-09 | director |
PFE | Pfizer Inc | 2013-05-15 | Senior Vice President |
ZTS | Zoetis Inc | 2013-02-06 | director |
SQZB | SQZ Biotechnologies Co | 2021-12-13 | director & 10 percent owner |
TALK | Talkspace Inc | 2020-06-08 | director |
HCIIU | Hudson Executive Investment Corp II | 2021-01-25 | director |
HCII | Hudson Executive Investment Corp II | 2021-01-25 | director |
Amy W Schulman Latest Holdings Summary
Amy W Schulman currently owns a total of 4 stocks. Among these stocks, Amy W Schulman owns 227,003 shares of Pfizer Inc (PFE) as of May 15, 2013, with a value of $6 Million and a weighting of 86.43%. Amy W Schulman owns 5,000 shares of Zoetis Inc (ZTS) as of February 6, 2013, with a value of $799,800 and a weighting of 11.91%. Amy W Schulman also owns 31,681 shares of Cyclerion Therapeutics Inc (CYCN) as of April 8, 2019, with a value of $97,577 and a weighting of 1.45%. The other 1 stocks SQZ Biotechnologies Co (SQZB) have a combined weighting of 0.21% among all his current holdings.
Latest Holdings of Amy W Schulman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PFE | Pfizer Inc | 2013-05-15 | 227,003 | 25.58 | 5,806,737 |
ZTS | Zoetis Inc | 2013-02-06 | 5,000 | 159.96 | 799,800 |
CYCN | Cyclerion Therapeutics Inc | 2019-04-08 | 31,681 | 3.08 | 97,577 |
SQZB | SQZ Biotechnologies Co | 2021-12-13 | 301,955 | 0.05 | 14,041 |
Holding Weightings of Amy W Schulman
Amy W Schulman Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 70,000 shares on May 15, 2013, which brought Amy W Schulman around $2 Million.
According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Zoetis Inc (ZTS) over the past 5 years. The most-recent trade in Zoetis Inc is the acquisition of 5,000 shares on February 6, 2013, which cost Amy W Schulman around $130,000.
According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years. The most-recent trade in Cyclerion Therapeutics Inc is the acquisition of 31,306 shares on April 8, 2019, which cost Amy W Schulman around $10 Million.
More details on Amy W Schulman's insider transactions can be found in the Insider Trading History of Amy W Schulman table.Insider Trading History of Amy W Schulman
- 1
Amy W Schulman Trading Performance
GuruFocus tracks the stock performance after each of Amy W Schulman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy W Schulman is -6.89%. GuruFocus also compares Amy W Schulman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy W Schulman within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amy W Schulman's insider trading performs compared to the benchmark.
Performance of Amy W Schulman
Average Return
-47.92%
Outperforming Transactions
0%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 11.58 | -6.89 | -36 | -47.92 | -48.18 | -45.18 |
Relative Return to S&P 500(%) | 9.08 | -10.26 | -40.23 | -57.09 | -58.43 | -55.91 |
Amy W Schulman Ownership Network
Ownership Network List of Amy W Schulman
Ownership Network Relation of Amy W Schulman
Amy W Schulman Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Amy W Schulman is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & CLO & Secretary Indrani Lall Franchini .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Amy W Schulman made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .
In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Amy W Schulman Mailing Address
Above is the net worth, insider trading, and ownership report for Amy W Schulman. You might contact Amy W Schulman via mailing address: Pfizer Inc. Attn: Corporate Secretary, 235 East 42nd Street, New York Ny 10017.